Differentiating solitary pulmonary metastases in patients with extrapulmonary neoplasmas using FDG-PET

Cancer Investigation

Volumn 21, Issue 1, 2003, Pages 47-52

  Hsu, Wu Huei ^a   Hsu, Nan Yung ^a   Shen, Yeh You ^b   Yen, Ruoh Fang ^c   Kao, Chia Hung ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

18F fluoro 2 deoxyglucose; Positron emission tomography; Solitary pulmonary metastases

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; LUNG CANCER; LUNG METASTASIS; MALE; METASTASIS; ONCOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; COIN LESION, PULMONARY; DIAGNOSIS, DIFFERENTIAL; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0037216087     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1081/CNV-120016403     Document Type: Article

References (22)

1. Webb, W.R.; Gatsonis, C.; Zerhouni, E.A.; et al. CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology 1991, 178, 705-713.
2. Hubner, K.F.; Buonocore, E.; Singh, S.K.; Gould, H.R.; Cotton, D.W. Characterization of chest masses by FDG positron emission tomography. Clin. Nucl. Med. 1995, 20, 293-298.
3. Duhaylongsod, F.G.; Lowe, V.J.; Pat, E.F., Jr.; Vaughn, A.L.; Coleman, R.E.; Wolfe, W.G. Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET). J. Thorac. Cardiovasc. Surg. 1995, 110, 130-140.
4. Dewan, N.A.; Reeb, S.D.; Gupta, N.C.; Gobar, L.S.; Scott, W.J. PET-FDG imaging and transthoracic needle lung aspiration biopsy in evaluation of pulmonary lesions. A comparative risk-benefit analysis. Chest 1995, 108, 441-446.
5. Strauss, L.G. Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients. Eur. J. Nucl. Med. 1996, 23, 1409-1415.
6. Knight, S.B.; Delbeke, D.; Stewart, J.R.; Sandler, M.P. Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patients with and without a history of prior malignancy. Chest 1996, 109, 982-988.
7. Lowe, V.J.; Duhaylongsod, F.G.; Patz, E.F.; et al. Pulmonary abnormalities and PET data analysis: a retrospective study. Radiology 1997, 202, 435-439.
8. Erasmus, J.J.; McAdms, H.P.; Patz, E.F.; Coleman, R.E.; Ahuma, V.; Goodman, P.C. Evaluation of primary pulmonary carcinoid tumors using position emission tomography with 18F-fluorodeoxyglucose. AJR 1998, 170, 1369-1373.
9. Higashi, K.; Ueda, Y.; Seki, H.; et al. Fluorine-18-FDG PET imaging is negative in bronchioalveolar lung carcinoma. J. Nucl. Med. 1998, 39, 1016-1020.
10. Delbeke, D.; Martin, W.H.; Sandler, M.P.; Chapman, W.C.; Wright, J.K., Jr.; Pinson, C.W. Evaluation of benign vs malignant hepatic lesions with positron emission tomography. Arch. Surg. 1998, 133, 510-516.
11. Farber, L.A.; Benard, F.; Machtay, M.; et al. Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography. Laryngoscope 1999, 109, 970-975.
12. Montravers, F.; Grahek, D.; Kerrou, K.; et al. Evaluation of FDG uptake by renal malignancies (primary tumor of metastases) using a coincidence detection gamma camera. J. Nucl. Med. 2000, 41, 78-84.
13. Palmedo, H.; Bender, H.; Grunwald, F.; et al. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and technetium-99m methoxyisobutylisonitrile scintimammography in the detection of breast tumours. Eur. J. Nucl. Med. 1997, 24, 1138-1145.
14. Cremerius, U.; Wildberger, J.E.; Borchers, H.; et al. Does positron emission tomography using 18-fluoro-2-deoxyglucose improve clinical staging of testicular cancer-Results of a study in 50 patients. Urology 1999, 54, 900-904.
15. Hubner, K.F.; Buonocore, E.; Singh, S.K.; Gould, H.R.; Cotton, D.W. Characterization of chest masses by FDG positron emission tomography. Clin. Nucl. Med. 1995, 20, 293-298.
16. Duhaylongsod, F.G.; Lowe, V.J.; Patz, E.F., Jr.; Vaughn, A.L.; Coleman, R.E.; Wolf, W.G. Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET). J. Thorac. Cardiovasc. Surg. 1995, 110, 130-140.
17. Knight, S.B.; Delbeke, D.; Stewart, J.R.; Sandler, M.P. Evaluation of pulmonary lesions with FDG-PET, Comparison of findings in patients with and without a history of prior malignancy. Chest 1996, 109, 982-988.
18. Gupta, N.C.; Maloof, J.; Gunel, E. Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET. J. Nucl. Med. 1996, 37, 943-948.
19. Lowe, V.J.; Duhaylongsod, F.G.; Patz, E.F.; et al. Pulmonary abnormalities and PET data analysis: a retrospective study. Radiology 1997, 202, 435-439.
20. Prauer, H.W.; Weber, W.A.; Romer, W.; Treumann, T.; Ziegler, S.I.; Schwaiger, M. Controlled prospective study of positron emission tomography using the glucose analogue [18F] fluorodeoxyglucose in the evaluation of pulmonary nodules. Br. J. Surg. 1998, 85, 1506-1511.
21. Ber, G.M.; Gupta, N.C.; Murray, G.F. Positron emission tomography imaging with fluorodeoxyglucose is efficacious in evaluating malignant pulmonary disease. J. Thorac. Cardiovasc. Surg. 1999, 117, 719-727.
22. , Halter, G.; Storck; Guhlmann, A.; Frank, J.; Grosse, S.; Liewald, F. FDG positron emission tomography in diagnosis of peripheral pulmonary focal lesions. Thorac. Cardiovasc. Surg. 2000, 48, 97-101.